Treating Bone Loss Ups Survival for Patients With Breast Cancer

Long-term data from a trial of adjuvant denosumab in patients with breast cancer suggest a survival benefit in addition to reduced fractures and increased bone density.
Medscape Medical News
Long-term data from a trial of adjuvant denosumab in patients with breast cancer suggest a survival benefit in addition to reduced fractures and increased bone density.
Medscape Medical News